GlassScriptPhysician profile
Marc A Sarran
NPI 1902283450
$5,967.43
in general payments reported to CMS, 2019-2025
11 companies · $550 in 2025
The $550 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,105 · 2020: $189 · 2021: $90.01 · 2022: $2,379 · 2023: $535 · 2024: $1,120 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354 · Travel and Lodging: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,354.11 |
| Travel and Lodging | $850.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,756.03 | 2019-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $1,160.00 | 2022 | |
| Medtronic, INC. | $1,057.84 | 2024-2025 | Signia, Sonicision, Progrip |
| W. L. Gore & Associates, INC. | $314.27 | 2024-2025 | Gore Enform Preperitoneal Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce, Seamguard |
| Davol INC. | $285.51 | 2022-2024 | Phasix Mesh |
| Kerecis Limited | $188.96 | 2020 | |
| Acera Surgical, INC. | $90.01 | 2021 | |
| Solventum Corporation | $38.46 | 2024 | Prevena |
| Medical Device Business Services, INC. | $30.90 | 2022 | |
| Novo Nordisk INC | $27.77 | 2025 | Wegovy |
| Pacira Pharmaceuticals Incorporated | $17.68 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Sarran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.